MRPL35 and cancer: Herein, we observed decreased glutamine consumption, α‐KG production, and glutamate generation after MRPL35 silencing in NSCLC cells, implying that MRPL35 silencing induced glutamine metabolism inhibition to prevent cancer cells from gaining energy.